» Articles » PMID: 24872422

MPBind: a Meta-motif-based Statistical Framework and Pipeline to Predict Binding Potential of SELEX-derived Aptamers

Overview
Journal Bioinformatics
Specialty Biology
Date 2014 May 30
PMID 24872422
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Aptamers are 'synthetic antibodies' that can bind to target molecules with high affinity and specificity. Aptamers are chemically synthesized and their discovery can be performed completely in vitro, rather than relying on in vivo biological processes, making them well-suited for high-throughput discovery. However, a large fraction of the most enriched aptamers in Systematic Evolution of Ligands by EXponential enrichment (SELEX) rounds display poor binding activity. Here, we present MPBind, a Meta-motif-based statistical framework and pipeline to Predict the BIND: ing potential of SELEX-derived aptamers. Using human embryonic stem cell SELEX-Seq data, MPBind achieved high prediction accuracy for binding potential. Further analysis showed that MPBind is robust to both polymerase chain reaction amplification bias and incomplete sequencing of aptamer pools. These two biases usually confound aptamer analysis.

Availability And Implementation: MPBind software and documents are available at http://www.morgridge.net/MPBind.html. The human embryonic stem cells whole-cell SELEX-Seq data are available at http://www.morgridge.net/Aptamer/.

Citing Articles

AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers.

Ruiz-Ciancio D, Veeramani S, Singh R, Embree E, Ortman C, Thiel K Mol Ther Nucleic Acids. 2024; 35(4):102358.

PMID: 39507401 PMC: 11539416. DOI: 10.1016/j.omtn.2024.102358.


Selection, characterization, and biosensing applications of DNA aptamers targeting cyanotoxin BMAA.

Santiago-Maldonado X, Rodriguez-Martinez J, Lopez L, Cunci L, Bayro M, Nicolau E RSC Adv. 2024; 14(20):13787-13800.

PMID: 38681844 PMC: 11046380. DOI: 10.1039/d4ra02384f.


Diagnostic and Therapeutic Aptamers: A Promising Pathway to Improved Cardiovascular Disease Management.

Di Mauro V, Lauta F, Modica J, Appleton S, de Franciscis V, Catalucci D JACC Basic Transl Sci. 2024; 9(2):260-277.

PMID: 38510714 PMC: 10950404. DOI: 10.1016/j.jacbts.2023.06.013.


Aptamers as an approach to targeted cancer therapy.

Mahmoudian F, Ahmari A, Shabani S, Sadeghi B, Fahimirad S, Fattahi F Cancer Cell Int. 2024; 24(1):108.

PMID: 38493153 PMC: 10943855. DOI: 10.1186/s12935-024-03295-4.


AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers.

Ruiz-Ciancio D, Veeramani S, Embree E, Ortman C, Thiel K, Thiel W bioRxiv. 2023; .

PMID: 38014343 PMC: 10680646. DOI: 10.1101/2023.11.13.566453.


References
1.
Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

2.
Dittmar K, Jiang P, Park J, Amirikian K, Wan J, Shen S . Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing. Mol Cell Biol. 2012; 32(8):1468-82. PMC: 3318588. DOI: 10.1128/MCB.06536-11. View

3.
Sassanfar M, Szostak J . An RNA motif that binds ATP. Nature. 1993; 364(6437):550-3. DOI: 10.1038/364550a0. View

4.
Ng E, Shima D, Calias P, Cunningham Jr E, Guyer D, Adamis A . Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 2006; 5(2):123-32. DOI: 10.1038/nrd1955. View

5.
Thiel W, Bair T, Wyatt Thiel K, Dassie J, Rockey W, Howell C . Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Ther. 2011; 21(4):253-63. PMC: 3198618. DOI: 10.1089/nat.2011.0288. View